SLAM
DXCM icon

Swiss Life Asset Management’s DexCom DXCM Stock Holding History

Swiss Life Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96M Buy
88,549
+16,880
+24% +$1.12M 0.02% 430
2026
Q1 		$4.5M Buy
71,669
+10,002
+16% +$697K 0.02% 428
2025
Q4 		$4.09M Sell
61,667
-24,303
-28% -$1.57M 0.02% 449
2025
Q3 		$5.78M Buy
85,970
+759
+0.9% +$60.1K 0.03% 372
2025
Q2 		$7.44M Buy
85,211
+27,666
+48% +$2.17M 0.04% 292
2025
Q1 		$3.93M Sell
57,545
-5,046
-8% -$412K 0.03% 376
2024
Q4 		$4.86M Buy
62,591
+5,657
+10% +$419K 0.04% 316
2024
Q3 		$3.82M Sell
56,934
-3,028
-5% -$249K 0.04% 289
2024
Q2 		$6.8M Buy
59,962
+3,453
+6% +$437K 0.08% 212
2024
Q1 		$7.84M Sell
56,509
-20,682
-27% -$2.6M 0.11% 170
2023
Q4 		$9.59M Buy
77,191
+31,114
+68% +$3.18M 0.12% 204
2023
Q3 		$4.3M Sell
46,077
-35,808
-44% -$4.04M 0.07% 317
2023
Q2 		$10.5M Buy
81,885
+18,625
+29% +$2.25M 0.16% 166
2023
Q1 		$7.35M Buy
63,260
+6,749
+12% +$755K 0.11% 232
2022
Q4 		$6.41M Sell
56,511
-5,034
-8% -$553K 0.11% 227
2022
Q3 		$4.96M Sell
61,545
-785
-1% -$66.5K 0.09% 260
2022
Q2 		$4.65M Buy
62,330
+8,394
+16% +$766K 0.08% 292
2022
Q1 		$6.9M Sell
53,936
-1,368
-2% -$150K 0.1% 229
2021
Q4 		$7.42M Sell
55,304
-16,260
-23% -$2.34M 0.1% 247
2021
Q3 		$9.78M Buy
71,564
+3,280
+5% +$414K 0.14% 184
2021
Q2 		$22.7M Buy
68,284
+9,488
+16% +$911K 0.23% 74
2021
Q1 		$5.28M Buy
58,796
+3,476
+6% +$326K 0.08% 294
2020
Q4 		$5.11M Buy
55,320
+44,196
+397% +$3.95M 0.07% 288
2020
Q3 		$1.15M Buy
11,124
+4,248
+62% +$444K 0.02% 362
2020
Q2 		$697K Buy
+6,876
New +$615K 0.01% 401

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Swiss Life Asset Management's DXCM Position: Q2 2026 in Review

Swiss Life Asset Management increased its DexCom (DXCM) stake by 24% in Q2 2026, buying an estimated $1.12M and bringing the position to 88,549 shares worth $5.96M. The position accounts for 0.02% of the portfolio, ranked #430.

Swiss Life Asset Management first reported a position in DXCM in Q2 2020 and has held it in 25 quarters since. The position peaked at $22.7M in Q2 2021. 662 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Swiss Life Asset Management held 88,549 shares of DexCom worth $5.96M as of Q2 2026.
  • Swiss Life Asset Management bought 16,880 DexCom shares in Q2 2026, an estimated $1.12M.
  • DexCom made up 0.02% of Swiss Life Asset Management's portfolio in Q2 2026, its #430 holding.
  • Swiss Life Asset Management first reported a position in DexCom in Q2 2020 and has held it in 25 quarters since.
  • Swiss Life Asset Management's DexCom position peaked at $22.7M in Q2 2021.
  • 662 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.